Haleon Plc ADR (HLN1N)
BMV
Closed
Oct 6, 2026
Day's Range
171.0052 wk Range
159.85Overview - HLN1N - Haleon Plc ADR
Key Statistics
Valuation
Enterprise Value
17.78T
P/E (Trailing)
‪20.45‬
Price / Sales (TTM)
‪67.43‬
Price / Book
‪2.01‬
EV / EBITDA
‪269.36‬
Profitability
Gross Margin
‪55.38%‬
Profit Margin
‪14.55%‬
Operating Margin
‪23.93%‬
Return on Assets
‪5.08%‬
Return on Equity
‪10.09%‬
Ownership
Shares Outstanding
8.90B
Float
4.42B
Held by Insiders
‪0.01%‬
Held by Institutions
‪13.65%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪171.00‬
200-Day Avg
‪173.09‬
Dividends
Payout Ratio
‪39.53%‬
Frequency
Semi-Annual
Market Cap - HLN1N - Haleon Plc ADR
Peers - HLN1N - Haleon Plc ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BMV.
Profile Summary - HLN1N - Haleon Plc ADR
About
Haleon Plc ADR is an American depositary receipt representing Haleon plc, a consumer healthcare company headquartered in Weybridge, United Kingdom. Haleon develops, manufactures, and markets a broad range of self-care products focused on everyday health needs, including oral health, pain relief, respiratory care,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
